A clearer reading

The antimicrobial potential of cannabidiol

Study preparation, population, findings and limitations with original source links.

Content reviewed 2026-10-25 · Local preview

Back to all research · More in Antimicrobial models

AnimalIn vitro2021-01-19

Antimicrobial models · CBD

Communications biology · PMID 33469147

Bacterial assays and animal experiments

Studied preparation
CBD and related compounds studied in defined preclinical systems.
Population / model
Bacterial cultures and biofilms, with complementary in-vivo experiments.
What was observed
The work examined bacterial growth, biofilms, mechanism and topical in-vivo activity.
Interpretation limit

Preclinical findings are not evidence that a retail CBD product treats infection in humans; no human infection trial was reported.

Online publication · Source checked 2026-10-25

Sources, registration and terms

Citation and publication date recorded; peer-review/preprint status not separately classified.

PMC full-text link is recorded; current access and reuse rights are not verified here.

No registration recorded for this paper; this is not a claim that none exists.

CBD / cannabidiol · Animal study · In vitro

Package comparison guides; not clinical equivalence

Suggest a source correction

Copy a note and share it with the person who sent this preview. This page does not send or store your note.

Nothing has been sent.